Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Antin, JH' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 86 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Antin, JH; Childs, R; Filipovich, AH; Giralt, S; Mackinnon, S; Spitzer, T; Weisdorf, D
      Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001Tandem Meetings

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    2. Ho, VT; Weller, E; Lee, SJ; Alyea, EP; Antin, JH; Soiffer, RJ
      Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    3. Porter, DL; Luger, SM; Duffy, KM; Stadtmauer, EA; Laport, G; Schuster, SJ; Orloff, G; Tsai, D; McDaid, K; Kathakali, A; Leonard, DGB; Antin, JH
      Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    4. Cutler, C; Antin, JH
      Peripheral blood stem cells for allogeneic transplantation: A review

      STEM CELLS
    5. Soiffer, RJ; Weller, E; Alyea, EP; Mauch, P; Webb, IL; Fisher, DC; Freedman, AS; Schlossman, RL; Gribben, J; Lee, S; Anderson, KC; Marcus, K; Stone, RM; Antin, JH; Ritz, J
      CD6+donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors

      JOURNAL OF CLINICAL ONCOLOGY
    6. Cutler, C; Giri, S; Jeyapalan, S; Paniagua, D; Viswanathan, A; Antin, JH
      Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis

      JOURNAL OF CLINICAL ONCOLOGY
    7. Lee, SJ; Fairclough, D; Parsons, SK; Soiffer, RJ; Fisher, DC; Schlossman, RL; Antin, JH; Weeks, JC
      Recovery after stem-cell transplantation for hematologic diseases

      JOURNAL OF CLINICAL ONCOLOGY
    8. Winston, DJ; Antin, JH; Wolff, SN; Bierer, BE; Small, T; Miller, KB; Linker, C; Kaizer, H; Lazarus, HM; Petersen, FB; Cowan, MJ; Ho, WG; Wingard, JR; Schiller, GJ; Territo, MC; Jiao, J; Petrarca, MA; Tonetta, SA
      A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    9. Lee, SJ; Fairclough, D; Antin, JH; Weeks, JC
      Discrepancies between patient and physician estimates for the success of stem cell transplantation

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    10. Schiff, D; O 'Neill, B; Wijdicks, E; Antin, JH; Wen, PY
      Gliomas arising in organ transplant recipients: An unrecognized complication of transplantation?

      NEUROLOGY
    11. Antin, JH
      Acute graft-versus-host disease: inflammation run amok?

      JOURNAL OF CLINICAL INVESTIGATION
    12. Kollman, C; Howe, CWS; Anasetti, C; Antin, JH; Davies, SM; Filipovich, AH; Hegland, J; Kamani, N; Kernan, NA; King, R; Ratanatharathorn, V; Weisdorf, D; Confer, DL
      Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

      BLOOD
    13. Lee, SJ; Klein, JP; Anasetti, C; Antin, JH; Loberiza, FR; Bowell, BJ; LeMaistre, CF; Litzow, MR; Marks, D; Waller, EK; Matlack, M; Giralt, S; Horowitz, MM
      The effect of pretransplant interferon therapy on the outcome of unrelateddonor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase

      BLOOD
    14. Vasconcelles, MJ; Bernardo, MVP; King, C; Weller, EA; Antin, JH
      Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    15. Lee, SJ; Klar, N; Weeks, JC; Antin, JH
      Predicting costs of stem-cell transplantation

      JOURNAL OF CLINICAL ONCOLOGY
    16. Nash, RA; Antin, JH; Karanes, C; Fay, JW; Avalos, BR; Yeager, AM; Przepiorka, D; Davies, S; Petersen, FB; Bartels, P; Buell, D; Fitzsimmons, W; Anasetti, C; Storb, R; Ratanatharathorn, V
      Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

      BLOOD
    17. Davies, SM; Kollman, C; Anasetti, C; Antin, JH; Gajewski, J; Casper, JT; Nademanee, A; Noreen, H; King, R; Confer, D; Kernan, NA
      Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the National Marrow Donor Program

      BLOOD
    18. Schiffer, CA; Miller, K; Larson, RA; Amrein, PC; Antin, JH; Zani, VJ; Stone, RM
      A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia

      BLOOD
    19. McGlave, PB; Shu, XO; Wen, WQ; Anasetti, C; Nadermanee, A; Champlin, R; Antin, JH; Kernan, NA; King, R; Weisdorf, DJ
      Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9years' experience of the National Marrow Donor Program

      BLOOD
    20. Porter, DL; Collins, RH; Hardy, C; Kernan, NA; Drobyski, WR; Giralt, S; Flowers, MED; Casper, J; Leahey, A; Parker, P; Mick, R; Bate-Boyle, B; King, R; Antin, JH
      Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions

      BLOOD
    21. McGrail, LH; Sehn, LH; Weiss, RB; Robson, MR; Antin, JH; Byrd, JC
      Pancreatitis during therapy of acute myeloid leukemia: Cytarabine related?

      ANNALS OF ONCOLOGY
    22. Porter, DL; Connors, JM; Van Deerlin, VMD; Duffy, KM; McGarigle, C; Saidman, SL; Leonard, DGB; Antin, JH
      Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies

      JOURNAL OF CLINICAL ONCOLOGY
    23. Sehn, LH; Alyea, EP; Weller, E; Canning, C; Lee, S; Ritz, J; Antin, JH; Soiffer, RJ
      Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneicbone marrow transplantation for chronic myelogenous leukemia: Impact of donor lymphocyte infusion

      JOURNAL OF CLINICAL ONCOLOGY
    24. Porter, DL; Antin, JH
      The graft-versus-leukemia effects of allogeneic cell therapy

      ANNUAL REVIEW OF MEDICINE
    25. Benjamin, RJ; McGurk, S; Ralston, MS; Churchill, WH; Antin, JH
      ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation

      TRANSFUSION
    26. Benjamin, RJ; Antin, JH
      ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity

      TRANSFUSION
    27. PORTER DL; ANTIN JH
      INFUSION OF DONOR PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO TREAT RELAPSEAFTER TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA

      Hematology/oncology clinics of North America
    28. LEE SJ; ANASETTI C; HOROWITZ MM; ANTIN JH
      INITIAL THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA - PLAYING THE ODDS

      Journal of clinical oncology
    29. VANCE E; GEORGE S; GUINAN EC; WHEELER C; ANTIN JH; AMBROSINO DM; MOLRINE DC
      COMPARISON OF MULTIPLE IMMUNIZATION SCHEDULES FOR HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE AND TETANUS TOXOID VACCINES FOLLOWING BONE-MARROWTRANSPLANTATION

      Bone marrow transplantation
    30. CONNORS JM; KRONAUGE JF; CASTRONOVO F; MANNTING F; JONES AG; SIEFF C; ANTIN JH
      PHARMACOKINETICS AND BIODISTRIBUTION OF IN-111-DTPA-G-CSF IN NONHUMAN-PRIMATES

      The Journal of nuclear medicine
    31. BENJAMIN RJ; MCGURK S; RAISTON M; CHURCHILL WH; ANTIN JH
      ABO INCOMPATIBILITY AS A PROGNOSTIC FACTOR IN ALLOGENEIC STEM-CELL TRANSPLANTATION

      Transfusion
    32. CHANG G; MCGARIGLE C; SPITZER TR; MCAFEE SL; HARRIS F; PIERCY K; GOETZ MA; ANTIN JH
      A COMPARISON OF RELATED AND UNRELATED MARROW DONORS

      Psychosomatic medicine
    33. RATANATHARATHORN V; NASH RA; PRZEPIORKA D; DEVINE SM; KLEIN JL; WEISDORF D; FAY JW; NADEMANEE A; ANTIN JH; CHRISTIANSEN NP; VANDERJAGT R; HERZIG RH; LITZOW MR; WOLFF SN; LONGO WL; PETERSEN FB; KARANES C; AVALOS B; STORB R; BUELL DN; MAHER RM; FITZSIMMONS WE; WINGARD JR
      PHASE-III STUDY COMPARING METHOTREXATE AND TACROLIMUS (PROGRAF, FK506) WITH METHOTREXATE AND CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION

      Blood
    34. RICHARDSON PG; ELIAS AD; KRISHNAN A; WHEELER C; NATH R; HOPPENSTEADT D; KINCHLA NM; NEUBERG D; WALLER EK; ANTIN JH; SOIFFER R; VREDENBURGH J; LILL M; WOOLFREY AE; BEARMAN SI; IACOBELLI M; FAREED J; GUINAN EC
      TREATMENT OF SEVERE VENOOCCLUSIVE DISEASE WITH DEFIBROTIDE - COMPASSIONATE USE RESULTS IN RESPONSE WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION

      Blood
    35. LEE SJ; ANASETTI C; KUNTZ KM; PATTEN J; ANTIN JH; WEEKS JC
      THE COSTS AND COST-EFFECTIVENESS OF UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA

      Blood
    36. PRZEPIORKA D; PHILLIPS GL; RATANATHARATHORN V; COTTLERFOX M; SEHN LH; ANTIN JH; LEBHERZ D; AWWAD M; HOPE J; MCCLAIN JB
      A PHASE-II STUDY OF BTI-322, A MONOCLONAL ANTI-CD2 ANTIBODY, FOR TREATMENT OF STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE

      Blood
    37. SEHN LH; ANTIN JH; SHULMAN LN; MAUCH P; ELIAS A; KADIN ME; WHEELER C
      PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE MEDIASTINUM - OUTCOME FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC-CELL TRANSPLANTATION

      Blood
    38. ZIEGLER TR; BYE RL; PERSINGER RL; YOUNG LS; ANTIN JH; WILMORE DW
      EFFECTS OF GLUTAMINE SUPPLEMENTATION ON CIRCULATING LYMPHOCYTES AFTERBONE-MARROW TRANSPLANTATION - A PILOT-STUDY

      The American journal of the medical sciences
    39. COLLINS RH; SHPILBERG O; DROBYSKI WR; PORTER DL; GIRALT S; CHAMPLIN R; GOODMAN SA; WOLFF SN; HU W; VERFAILLIE C; LIST A; DALTON W; OGNOSKIE N; CHETRIT A; ANTIN JH; NEMUNAITIS J
      DONOR LEUKOCYTE INFUSIONS IN 140 PATIENTS WITH RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Journal of clinical oncology
    40. BALLEN KK; GILLILAND DG; GUINAN EC; HSIEH CC; PARSONS SK; RIMM IJ; FERRARA JLM; BIERER BE; WEINSTEIN HJ; ANTIN JH
      BONE-MARROW TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASIA - COMPARISON WITH PRIMARY MYELODYSPLASIA

      Bone marrow transplantation
    41. ANDRYKOWSKI MA; CARPENTER JS; GREINER CB; ALTMAIER EM; BURISH TG; ANTIN JH; GINGRICH R; CORDOVA MJ; HENSLEEDOWNEY PJ
      ENERGY-LEVEL AND SLEEP QUALITY FOLLOWING BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    42. CHAN CY; MOLRINE DC; ANTIN JH; WHEELER C; GUINAN EC; WEINSTEIN HJ; PHILLIPS NR; MCGARIGLE C; HARVEY S; SCHNIPPER C; AMBROSINO DM
      ANTIBODY-RESPONSES TO TETANUS TOXOID AND HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES FOLLOWING AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT)

      Bone marrow transplantation
    43. LEE SJ; CHURCHILL WH; KONUGRES A; GILLILAND DG; ANTIN JH
      IDIOPATHIC THROMBOCYTOPENIC PURPURA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - TREATMENT WITH ANTI-D IMMUNOGLOBULIN

      Bone marrow transplantation
    44. CHANG G; ANTIN JH; ORAV EJ; RANDALL U; MCGARIGLE C; BEHR HM
      SUBSTANCE-ABUSE AND BONE-MARROW TRANSPLANT

      The American journal of drug and alcohol abuse
    45. FOUNTAIN D; RALSTON M; HIGGINS N; GORLIN JB; UHL L; WHEELER C; ANTIN JH; CHURCHILL WH; BENJAMIN RJ
      LIQUID-NITROGEN FREEZERS - A POTENTIAL SOURCE OF MICROBIAL-CONTAMINATION OF HEMATOPOIETIC STEM-CELL COMPONENTS

      Transfusion
    46. BENJAMIN RJ; LINSLEY L; FOUNTAIN D; CHURCHILL WH; SIEFF C; CANNON ME; UHL L; GAYNES L; ANTIN JH; WHEELER C
      PREAPHERESIS PERIPHERAL-BLOOD CD34-CELL YIELD( MONONUCLEAR CELL COUNTS AS PREDICTORS OF PROGENITOR)

      Transfusion
    47. WEN PY; ALYEA EP; SIMON D; HERBST RS; SOIFFER RJ; ANTIN JH
      GUILLAIN-BARRE-SYNDROME FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Neurology
    48. CONNORS JM; KRONAUGE J; CASTRONOVO F; MANNTING F; JONES A; SIEFF C; ANTIN JH
      PHARMACOKINETICS AND BIODISTRIBUTION OF IN-111-DTPA-G-CSF NONHUMAN-PRIMATES

      Blood
    49. LEE SJ; ANASETTI C; KUNTZ KM; PATTEN J; ANTIN JH; WEEKS JC
      THE COST-EFFECTIVENESS OF UNRELATED DONOR BONE-MARROW TRANSPLANTATION(URD BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)

      Blood
    50. SEHN LH; ANTIN JH; WELLER E; ALYEA EP; CANNING C; RITZ J; SOIFFER RJ
      OUTCOME FOLLOWING T-CELL DEPLETED (TCD) VERSUS NON-T-CELL DEPLETED (NON-TCD) ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) - IMPACT OF DONOR LYMPHOCYTE INFUSIONS (DLI)

      Blood
    51. RICHARDSON PG; ELIAS AD; KRISHNAN A; WHEELER C; NATH R; HOPPENSTEADT D; WALLER EK; ANTIN JH; SOIFFER RJ; VREDENBURGH J; BEARMAN SI; IACOBELLI M; FAREED J; GUINAN EC
      TREATMENT OF SEVER VENOOCCLUSIVE DISEASE (VOD) WITH DEFIBROTIDE (DF) - COMPASSIONATE USE RESULTS IN EFFICACY WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION

      Blood
    52. VANCE EA; GEORGE S; GUINAN EC; WHEELER C; ANTIN JH; AMBROSINO DM; MOLRINE DC
      A COMPARISON OF DIFFERENT IMMUNIZATION SCHEDULES WITH HIB-CONJUGATE AND TETANUS TOXOID VACCINES FOLLOWING BMT

      Blood
    53. PORTER DL; CONNORS JM; DOYLE B; MCGARIGLE C; SAIDMAN S; VANDEERLIN V; LEONARD D; ANTIN JH
      DONOR LEUKOCYTE INFUSIONS (DLI) AS PRIMARY ALLOGENEIC ADOPTIVE IMMUNOTHERAPY FOR PATIENTS WITH MALIGNANCIES

      Blood
    54. LEE BSJ; WEGNER SA; MCGARIGLE CJ; BIERER BE; ANTIN JH
      TREATMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE WITH CLOFAZIMINE

      Blood
    55. LEE SJ; KUNTZ KM; HOROWITZ MM; MCGLAVE PB; GOLDMAN JM; SOBOCINSKI KA; HEGLAND J; KOLLMAN C; PARSONS SK; WEINSTEIN MC; WEEKS JC; ANTIN JH
      UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA - A DECISION-ANALYSIS

      Annals of internal medicine
    56. PORTER DL; ROTH MS; LEE SJ; MCGARIGLE C; FERRARA JLM; ANTIN JH
      ADOPTIVE IMMUNOTHERAPY WITH DONOR MONONUCLEAR CELL INFUSIONS TO TREATRELAPSE OF ACUTE-LEUKEMIA OR MYELODYSPLASIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    57. WOO SB; ALLEN CM; ORDEN A; PORTER D; ANTIN JH
      NON-GINGIVAL SOFT-TISSUE GROWTHS AFTER ALLOGENEIC MARROW TRANSPLANTATION

      Bone marrow transplantation
    58. MOLRINE DC; GUINAN EC; ANTIN JH; WHEELER C; PARSONS SK; WEINSTEIN HJ; MCGARIGLE C; BLANDING P; PHILLIPS NR; CIAMARRA A; GEORGE S; AMBROSINO DM
      HAEMOPHILUS-INFLUENZAE TYPE-B (HIB)-CONJUGATE IMMUNIZATION BEFORE BONE-MARROW HARVEST IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    59. NICHOLS WC; ANTIN JH; LUNETTA KL; TARRY VH; HERTEL CE; WHEATLEY MA; ARNOLD ND; SIEMIENIAK DR; BOEHNKE M; GINSBURG D
      POLYMORPHISM OF ADHESION MOLECULE CD31 IS NOT A SIGNIFICANT RISK FACTOR FOR GRAFT-VERSUS-HOST DISEASE

      Blood
    60. HOUDE LL; SEHN LH; ROBSON MR; ANTIN JH; STRICKLAND WR; BYRD JC
      PANCREATITIS DURING THERAPY OF ACUTE MYELOID-LEUKEMIA - CYTARABINE RELATED

      Blood
    61. RATANATHARATHORN V; NASH RA; DEVINE SM; PRZEPIORKA D; KLEIN JL; WEISDORF DJ; FAY JW; NADEMANEE AP; ANTIN JH; KARANES C; AVALOS BR; CHRISTIANSEN NP; VANDERJAGT RH; HERZIG RH; LITZOW MR; WOLFF SN; LONGO WR; PETERSEN FB; BUELL DN; MAHER RM; FITZSIMMONS WE; WINGARD JR
      PHASE-III STUDY COMPARING TACROLIMUS (PROGRAF(R), FK506) WITH CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE (GVHD) PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    62. LEE SJ; KUNTZ KM; HOROWITZ MM; MCGLAVE PB; HEGLAND J; KOLLMAN C; WEEKS JC; ANTIN JH
      A DECISION-ANALYSIS OF UNRELATED DONOR TRANSPLANTATION (URD BMT) FOR CML

      Blood
    63. FAY JW; WINGARD JR; ANTIN JH; COLLINS RH; PINEIRO LA; BLAZAR BR; SARAL R; BIERER BE; PRZEPIORKA D; FITZSIMMONS WE; MAHER RM; WEISDORF DJ
      FK506 (TACROLIMUS) MONOTHERAPY FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HISTOCOMPATIBLE SIBLING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    64. MOLRINE DC; GUINAN EC; ANTIN JH; PARSONS SK; WEINSTEIN HJ; WHEELER C; MCGARIGLE C; BLANDING P; PHILLIPS NR; KINSELLA K; DEANS K; CIAMARRA A; GOORIN A; GEORGE S; AMBROSINO DM
      DONOR IMMUNIZATION WITH HAEMOPHILUS-INFLUENZAE TYPE-B (HIB)-CONJUGATEVACCINE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    65. PORTER DL; ANTIN JH
      ADOPTIVE IMMUNOTHERAPY FOR RELAPSED LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Leukemia & lymphoma
    66. MITUS AJ; ANTIN JH; MILLER KB
      NEW AND IMPROVED TITLES - REPLY

      Journal of clinical oncology
    67. MITUS AJ; MILLER KB; SCHENKEIN DP; RYAN HF; PARSONS SK; WHEELER C; ANTIN JH
      IMPROVED SURVIVAL FOR PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

      Journal of clinical oncology
    68. SCHWARTZ RB; BRAVO SM; KLUFAS RA; HSU LG; BARNES PD; ROBSON CD; ANTIN JH
      CYCLOSPORINE NEUROTOXICITY AND ITS RELATIONSHIP TO HYPERTENSIVE ENCEPHALOPATHY - CT AND MR FINDINGS IN 16 CASES

      American journal of roentgenology
    69. ANDRYKOWSKI MA; BRADY MJ; GREINER CB; ALTMAIER EM; BURISH TG; ANTIN JH; GINGRICH R; MCGARIGLE C; HENSLEEDOWNEY PJ
      RETURNING TO NORMAL FOLLOWING BONE-MARROW TRANSPLANTATION - OUTCOMES,EXPECTATIONS AND INFORMED CONSENT

      Bone marrow transplantation
    70. BENJAMIN RJ; LINSLEY L; AXELROD JD; CHURCHILL WH; SIEFF C; SHULMAN LN; ELIAS A; AYASH L; MALACHOWSKI ME; UHL L; GAYNES L; MCCAULEY M; THOMPSON L; MAZANET R; ANTMAN K; SCHNIPPER L; TEPLER I; ANTIN JH; WHEELER C
      THE COLLECTION AND EVALUATION OF PERIPHERAL-BLOOD PROGENITOR CELLS SUFFICIENT FOR REPETITIVE CYCLES OF HIGH-DOSE CHEMOTHERAPY SUPPORT

      Transfusion
    71. MOLRINE DC; GUINAN EC; PARSON SK; WEINSTEIN HJ; ANTIN JH; WHEELER C; PHILLIPS NR; KINSELLA K; DEANS K; CIAMARRA A; AMBROSINO DM
      DONOR IMMUNIZATION AND ANTIBODY-RESPONSES TO POLYSACCHARIDE (PS)-CONJUGATE VACCINE IN BONE-MARROW TRANSPLANTATION

      Pediatric research
    72. ANDRYKOWSKI MA; GREINER CB; ALTMAIER EM; BURISH TG; ANTIN JH; GINGRICH R; MCGARIGLE C; HENSLEEDOWNEY PJ
      QUALITY-OF-LIFE FOLLOWING BONE-MARROW TRANSPLANTATION - FINDINGS FROMA MULTICENTER STUDY

      British Journal of Cancer
    73. BALLEN KK; GILLILAND DG; GUINAN EC; PARSONS SK; RIMM IJ; FERRARA JLM; BIERER BE; WEINSTEIN HJ; ANTIN JH
      BONE-MARROW TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASIA - COMPARISON WITH PRIMARY MYELODYSPLASIA

      Blood
    74. NICHOLS WC; ANTIN JH; LUNETTA KL; MARTIN PJ; BLAZAR BR; CHAO NJ; SENITZER D; TAYLOR CA; TERRY VH; ARNOLD ND; SIEMIENIAK DR; BRUCK ME; MUHAMMAD SA; BOEHNKE M; GINSBURG D
      IDENTIFICATION OF NON-HLA LOCI CONTRIBUTING TO GRAFT-VERSUS-HOST DISEASE

      Blood
    75. GUINAN EC; MOLRINE DC; ANTIN JH; LEE MC; WEINSTEIN HJ; SALLAN SE; PARSONS SK; WHEELER C; GROSS W; MCGARIGLE C; BLANDING P; SCHIFFMAN G; FINBERG RW; SIBER GR; BOLON D; WANG M; CARIATI S; AMBROSINO DM
      POLYSACCHARIDE CONJUGATE VACCINE RESPONSES IN BONE-MARROW TRANSPLANT PATIENTS

      Transplantation
    76. MOLRINE DC; GUINAN EC; PARSONS SK; WEINSTEIN HJ; ANTIN JH; WHEELER C; PHILLIPS NR; KINSELLA K; DEANS K; GEORGE S; AMBROSINO DM
      ANTIBODY-RESPONSES TO MULTIPLE DOSES OF A POLYSACCHARIDE (PS)-CONJUGATE VACCINE POST BONE-MARROW TRANSPLANTATION

      Pediatric research
    77. PORTER DL; ROTH MS; MCGARIGLE C; FERRARA JLM; ANTIN JH
      INDUCTION OF GRAFT-VERSUS-HOST DISEASE AS IMMUNOTHERAPY FOR RELAPSED CHRONIC MYELOID-LEUKEMIA

      The New England journal of medicine
    78. ANTIN JH; WEINSTEIN HJ; GUINAN EC; MCCARTHY P; BIERER BE; GILLILAND DG; PARSONS SK; BALLEN KK; RIMM IJ; FALZARANO G; BLOEDOW DC; ABATE L; LEBSACK M; BURAKOFF SJ; FERRARA JLM
      RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE

      Blood
    79. PAI SY; FRUMAN DA; LEONG T; NEUBERG D; ROSANO TG; MCGARIGLE C; ANTIN JH; BIERER BE
      INHIBITION OF CALCINEURIN PHOSPHATASE-ACTIVITY IN ADULT BONE-MARROW TRANSPLANT PATIENTS TREATED WITH CYCLOSPORINE-A

      Blood
    80. MITUS AJ; ANTIN JH; RUTHERFORD CJ; MCGARIGLE CJ; GOLDBERG MA
      USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ALLOGENEIC BONE-MARROW TRANSPLANT DONOR-RECIPIENT PAIRS

      Blood
    81. SHULMAN LN; FRISARD B; ANTIN JH; WHEELER C; PINKUS G; MAGAURAN N; MAUCH P; NOBLES E; MASHAL R; CANELLOS G; TUNG N; KADIN M
      PRIMARY KI-1 ANAPLASTIC LARGE-CELL LYMPHOMA IN ADULTS - CLINICAL CHARACTERISTICS AND THERAPEUTIC OUTCOME

      Journal of clinical oncology
    82. ANTIN JH
      GRAFT-VERSUS-LEUKEMIA - NO LONGER AN EPIPHENOMENON

      Blood
    83. WHEELER C; SHULMAN LN; ELIAS A; AXELROD J; SIEFF C; CHURCHILL WH; AYASH L; GAYNES L; MCCAULEY M; THOMPSON L; MAZANET R; ANTMAN K; TEPLER I; SCHNIPPER L; WEGNER S; SCHWARTZ G; ANTIN JH
      SEQUENTIAL IFOSFAMIDE (I), CARBOPLATIN (C), AND ETOPOSIDE (E) WITH STEROIDS AND CYCLOPHOSPHAMIDE G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT (SPICE) IN RELAPSED LYMPHOMA/

      Blood
    84. PAI SY; FRUMAN D; LEONG T; ROSANO T; MCGARIGLE C; ANTIN JH; BIERER BE
      INHIBITION OF CALCINEURIN (CN) PHOSPHATASE-ACTIVITY IN BMT PATIENTS TREATED WITH CYCLOSPORINE-A (CSA)

      Blood
    85. BUSQUE L; MARAGH M; DEHART D; MCGARIGLE C; VOSE J; ARMITAGE J; MEISINGER D; WHEELER C; GAINES L; BELANGER R; HABEL F; DUNBAR C; CHAMPAGNE M; GROSS W; WEINSTEIN H; ANTIN JH; GILLIAND DG
      CLONALITY OF BONE-MARROW REPOPULATION AFTER ALLOGENEIC AND AUTOLOGOUSBONE-MARROW TRANSPLANTATION (ABMT)

      Blood
    86. MOORE FD; JACK RM; ANTIN JH
      PERIPHERAL-BLOOD NEUTROPHILS IN CHRONICALLY NEUTROPENIC PATIENTS RESPOND TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR WITH A SPECIFIC INCREASE IN CR-1 EXPRESSION AND CR-1 TRANSCRIPTION

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 03:07:57